3 Growth Stocks to Buy and Hold
The stock market's short-term volatility can sometimes cloud investors' judgment and cause panic selling. But history has demonstrated time and again that a buy-and-hold strategy is one of the best ways for the average person to generate wealth. So it pays to target stocks with solid prospects worth keeping through all the various market volatility.
In that spirit, we asked three Motley Fool contributors to discuss buy-and-hold-worthy growth stocks. Read on to find out why they picked Axsome Therapeutics (NASDAQ: AXSM), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX).
Prosper Junior Bakiny (Axsome Therapeutics): What a difference 12 months make. At this time last year, Axsome Therapeutics was generating no revenue; it had just one approved product to its name -- Sunosi, a narcolepsy therapy it had just acquired. But since then, the biotech has scored a major approval, namely that of major depressive disorder (MDD) medicine Auvelity.
Source Fool.com
Axsome Therapeutics Inc Aktie
Die Axsome Therapeutics Inc Aktie hat zu wenige Einschätzungen, um eine Tendenz festzustellen.
Ein Kursziel von 100 € für Axsome Therapeutics Inc zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 84.04 €.
